CROUSDT
Crypto.com Coin / Tether USD
cryptoComposite

What you missed is that 'CRO is utter dog shit and it's en route to 10c

Just some history here, but I posted both of these this summer, and in each case SLS moved 100% shortly after the post. [https://www.reddit.com/r/Shortsqueeze/comments/1tby9tt/pay\_attention\_to\_sls\_for\_a\_potential\_squeeze/](https://www.reddit.com/r/Shortsqueeze/comments/1tby9tt/pay_attention_to_sls_for_a_potential_squeeze/) [https://www.reddit.com/r/Shortsqueeze/comments/1ua2v3q/sls\_looking\_like\_it\_may\_squeeze\_again/](https://www.reddit.com/r/Shortsqueeze/comments/1ua2v3q/sls_looking_like_it_may_squeeze_again/) For those unfamiliar with the context, SLS is a biotech company in a Phase 3 trial for a cancer vaccine targeting Leukemia (AML). All of the patients were transplant ineligible and in CR-2 (their second remission from Leukemia, with a median life expectancy of 5-8 months). An event occurs if a patient stops treatment or dies. The trial itself was derisked in December of 2024 with an interim analysis showing that the trial was on track to meet its primary endpoint and expected to end in late 2025. Instead, it ran through all of 2026. The 80th event was announced two weeks ago, meaning that results for the trial are imminent. They could feasibly be announced this week (especially with earnings tomorrow), though that would be a very quick turnaround as the CRO needs to validate all of the data and make sure none of the patients thought to be living are in fact alive. While I wouldn't call the trial a slam dunk, the bull case favors good results IMHO given the interim analysis and the overall length of the trial. Short interest: \~54M shares, 27% of the float, 9DTC. Borrow costs slightly elevated at 5% [SLS / SELLAS Life Sciences Group, Inc. Stock - Short Interest, Short Squeeze, Borrow Rates](https://fintel.io/ss/us/sls) SLS options chains have some pretty massive gamma to the upside for the last two weeks of November. The stock itself is practically a meme stock at this point. It's well known in retail circles (including a much higher than normal retail ownership) which will accelerate the move in either direction. The company is well capitalized (over 100M in the bank) and most of the warrant overhang is gone. It's generally believed that the company is positioning itself to be purchased by Big Pharma if the results are successful. This included restructuring the comp plan of the employees to reward a BO. As well, they employ something like 13 people. The smart play here would be running some short-term straddles in an attempt to time the announcement. Downside of a failed trial likely puts it in the $2-4 dollar range (currently sitting a little over 8). They do have a second drug in an accelerated Phase 2 trial, but I don't think that will play much into price action in the short term, though I believe there will be an update next week. Upside is easily double where it's at right now. We all saw what MRNA did, and that had a considerably higher market cap. SLS already hit 16 a few months ago and could quite possibly gap up to that or well beyond it. With that kind of short interest, margin calls would start coming right away if it popped. Gamblers are gonna gamble though, so pick your side. There's likely a lot more money to the upside, but some cheap puts could preserve your capital in the event that topline isn't good. I'm long 3000 derisked shares. I'm likely going options come Friday if news hasn't been announced. Not financial advice. I used only my regarded brain to write this. Good luck.

What’s the market sentiment for CDC and CRO?